Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Letizia Masi

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Minerva Gastroenterology|November 20, 2025
The molecular basis of sarcopenia in inflammatory bowel disease: from gut-muscle axis to therapeutic opportunitiesSara Troisi, Guglielmo Sicilia, Valentina Petito, et al.
Frontiers in Cellular and Infection Microbiology|May 14, 2026
Ecological patterns of the gut mycobiome and microbiome in ulcerative colitis across life stagesFrancesca Toto, Sabrina Cardile, Matteo Scanu, et al.
Metabolites|June 25, 2026
Dual Actions of Butyrate on Immunoepithelial Remodeling in Ex Vivo Intestinal Biopsies from Patients with Inflammatory Bowel DiseaseSara Troisi, Cesare Pane, Letizia Masi, et al.
Minerva Gastroenterology|March 19, 2026
Modulation of IL33/ST2 axis and mucosal healing in IBD: state of the art and future perspectivesGreta Migliore, Sara Troisi, Valentina Petito, et al.
Inflammatory Bowel Diseases|April 28, 2026
OCTN1 variants shape innate immunity and predict individual response to anti-TNFα in ulcerative colitis patients: An exploratory studyPierluigi Puca, Letizia Masi, Simone Parello, et al.
Inflammatory Bowel Diseases|June 30, 2024
Solute Transporter OCTN1/Slc22a4 Affects Disease Severity and Response to Infliximab in Experimental Colitis: Role of Gut Microbiota and Immune ModulationFederica Del Chierico, Letizia Masi, Valentina Petito, et al.
Journal of Crohn'S & Colitis|December 29, 2025
Inflammatory Bowel Disease is associated with increased intestinal extrachromosomal circular DNA: an emerging biomarker for IBD type and activityValentina Petito, Daniela Gerovska, Antonia Piazzesi, et al.
Cell Communication and Signaling : CCS|July 27, 2025
Intestinal inflammation and microbiota modulation impact cochlear function: emerging insights in gut-ear axisAnna Pisani, Valentina Petito, Fabiola Paciello, et al.
Inflammatory Bowel Diseases|June 6, 2023
Gut Microbiota Signatures Are Associated With Psychopathological Profiles in Patients With Ulcerative Colitis: Results From an Italian Tertiary IBD CenterFranco Scaldaferri, Antonio Maria D'Onofrio, Rosaria Calia, et al.
Journal of Clinical Medicine|September 13, 2025
Clinical Predictive Factors for the Development of Short Bowel Syndrome in a Cohort of Patients with Crohn's Disease: A Prospective StudyLaura Parisio, Angelo Del Gaudio, Jacopo Iaccarino, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Minerva Gastroenterology|November 20, 2025
The molecular basis of sarcopenia in inflammatory bowel disease: from gut-muscle axis to therapeutic opportunitiesSara Troisi, Guglielmo Sicilia, Valentina Petito, et al.
Frontiers in Cellular and Infection Microbiology|May 14, 2026
Ecological patterns of the gut mycobiome and microbiome in ulcerative colitis across life stagesFrancesca Toto, Sabrina Cardile, Matteo Scanu, et al.
Metabolites|June 25, 2026
Dual Actions of Butyrate on Immunoepithelial Remodeling in Ex Vivo Intestinal Biopsies from Patients with Inflammatory Bowel DiseaseSara Troisi, Cesare Pane, Letizia Masi, et al.
Minerva Gastroenterology|March 19, 2026
Modulation of IL33/ST2 axis and mucosal healing in IBD: state of the art and future perspectivesGreta Migliore, Sara Troisi, Valentina Petito, et al.
Inflammatory Bowel Diseases|April 28, 2026
OCTN1 variants shape innate immunity and predict individual response to anti-TNFα in ulcerative colitis patients: An exploratory studyPierluigi Puca, Letizia Masi, Simone Parello, et al.
Inflammatory Bowel Diseases|June 30, 2024
Solute Transporter OCTN1/Slc22a4 Affects Disease Severity and Response to Infliximab in Experimental Colitis: Role of Gut Microbiota and Immune ModulationFederica Del Chierico, Letizia Masi, Valentina Petito, et al.
Journal of Crohn'S & Colitis|December 29, 2025
Inflammatory Bowel Disease is associated with increased intestinal extrachromosomal circular DNA: an emerging biomarker for IBD type and activityValentina Petito, Daniela Gerovska, Antonia Piazzesi, et al.
Cell Communication and Signaling : CCS|July 27, 2025
Intestinal inflammation and microbiota modulation impact cochlear function: emerging insights in gut-ear axisAnna Pisani, Valentina Petito, Fabiola Paciello, et al.
Inflammatory Bowel Diseases|June 6, 2023
Gut Microbiota Signatures Are Associated With Psychopathological Profiles in Patients With Ulcerative Colitis: Results From an Italian Tertiary IBD CenterFranco Scaldaferri, Antonio Maria D'Onofrio, Rosaria Calia, et al.
Journal of Clinical Medicine|September 13, 2025
Clinical Predictive Factors for the Development of Short Bowel Syndrome in a Cohort of Patients with Crohn's Disease: A Prospective StudyLaura Parisio, Angelo Del Gaudio, Jacopo Iaccarino, et al.
Pageof 3